speb/financial-data huggingface dataset:
Financial ratios for CON.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 44.833333333333336
Shares outstanding: 200005983
Market cap (USD): 8966934904.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CON.DE — annual report dated 2024-12-31
Total revenue: 20913541666.666668
Gross profit: 5526041666.666667
Operating income: 1939583333.3333335
Net income: 1250000000
Capital expenditures: 27083333.333333336
Operating cash flow: 3056250000
Depreciation & amortization: 1157291666.6666667
Net tangible assets: 11007291666.666668
Owner earnings: 2380208333.3333335
Return on net tangible assets (%): 21.623923535535155
Capex to operating income (%): 1.3963480128893664
Buffett classification: The Great
Stock price: 46.854166666666664
P/E ratio: 7.496890929449999
Shares outstanding: 200005983
Book value: 15414583333.333332
P/B ratio: 0.6079381751142047
Market cap (USD): 9371113661.8125
Debt to equity: 0.46486011623192325
Current ratio: 1.257971827037634
Quick ratio: 0.829560585885486
Effective tax rate (%): 22.665148063781324
Interest coverage ratio: 5.115384615384616
COGS to revenue (%): 73.57672959107437
R&D to revenue (%): 2.639836628978433
SG&A to revenue (%): 14.175424615231357
Free cash flow (dilution-adjusted): 1956250000
Buyback yield (%): 0
Retained earnings: 11963541666.666668
Inventory turnover: 2.416489448715851
Receivables turnover: 2.784604715672677
Capitalized R&D asset: 5047856855.791963
ROCI (R&D-adjusted, %): -2.2972388839267786
Rosenberg metric: -0.9293656083373725
FCF margin (%): 9.353987149474523
Revenue growth (%): -54.558828854928656
Rule of 40 score: -45.20484170545413
Financial ratios for CON.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 46.854166666666664
Shares outstanding: 200005983
Market cap (USD): 9371113661.8125
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CON.DE — quarterly report dated 2025-03-31
Total revenue: 5331521739.130435
Gross profit: 1395652173.9130435
Operating income: 458695652.173913
Net income: 77173913.04347825
Capital expenditures: 3260869.565217391
Operating cash flow: 23913043.478260867
Depreciation & amortization: 302173913.04347825
Net tangible assets: 14310869565.21739
Owner earnings: 376086956.5217391
Return on net tangible assets (%): 2.6279811636032204
Capex to operating income (%): 0.7109004739336493
Buffett classification: The Great
Stock price: 48.69565217391304
P/E ratio: 31.550239571830986
Shares outstanding: 200005983
Book value: 16086956521.739128
P/B ratio: 0.6054235161081082
Market cap (USD): 9739421780.869564
Debt to equity: 0.44709459459459466
Current ratio: 1.6839600470035252
Quick ratio: 1.4688601645123385
Effective tax rate (%): 39.76608187134503
Interest coverage ratio: 5.2749999999999995
COGS to revenue (%): 73.82262996941895
R&D to revenue (%): 3.037716615698267
SG&A to revenue (%): 14.536187563710499
Free cash flow (dilution-adjusted): -188043478.26086956
Buyback yield (%): 0
Retained earnings: 12556521739.130434
Inventory turnover: 0.9890740234908494
Receivables turnover: 1.2857142857142858
Capitalized R&D asset: 161956521.73913044
ROCI (R&D-adjusted, %): 2.544703145083875
FCF margin (%): -3.527013251783894
Rule of 40 score: -3.527013251783894
Financial ratios for CON.DE — quarterly report dated 2025-06-30
Total revenue: 5712941176.470589
Gross profit: 1457647058.8235295
Operating income: 420000000
Net income: 614117647.0588236
Capital expenditures: 4705882.352941177
Operating cash flow: 303529411.7647059
Depreciation & amortization: 320000000
Net tangible assets: 4615294117.6470585
Owner earnings: 929411764.7058824
Return on net tangible assets (%): 20.137649757838393
Capex to operating income (%): 1.1204481792717087
Buffett classification: The Great
Stock price: 63.48235294117647
P/E ratio: 18.366852911199985
Shares outstanding: 200005983
Book value: 6402352941.176476
P/B ratio: 1.983153774840131
Market cap (USD): 12696850403.15294
Debt to equity: 1.5652333700845267
Current ratio: 1.1832480339533142
Quick ratio: 1.0328298589439522
Effective tax rate (%): -15.267175572519085
Interest coverage ratio: 4.25
COGS to revenue (%): 74.4851729818781
R&D to revenue (%): 2.8624382207578254
SG&A to revenue (%): 15.300658978583195
Free cash flow (dilution-adjusted): -20000000
Buyback yield (%): 0
Retained earnings: 3445882352.9411764
Inventory turnover: 1.0005532503457815
Receivables turnover: 1.3224400871459696
Capitalized R&D asset: 272040281.3299233
ROCI (R&D-adjusted, %): 3.0087327710712835
Rosenberg metric: 0.38278720884326917
FCF margin (%): -0.35008237232289946
Revenue growth (%): 7.154044492414707
Rule of 40 score: 6.803962120091808
Financial ratios for CON.DE — quarterly report dated 2025-09-30
Total revenue: 5823529411.764706
Gross profit: 1557647058.8235295
Operating income: 538823529.4117647
Net income: -882352941.1764706
Capital expenditures: 0
Operating cash flow: 645882352.9411765
Depreciation & amortization: 847058823.5294118
Net tangible assets: 3440000000
Owner earnings: -35294117.647058845
Return on net tangible assets (%): -1.025991792065664
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 63.247058823529414
Shares outstanding: 200005983
Book value: 4847058823.529411
P/B ratio: 2.609786807300971
Market cap (USD): 12649790171.858824
Debt to equity: 1.842718446601942
Current ratio: 1.3180037902716362
Quick ratio: 0.8999368288060644
Interest coverage ratio: 4.924731182795699
COGS to revenue (%): 73.25252525252526
R&D to revenue (%): 2.9090909090909096
SG&A to revenue (%): 14.585858585858588
Free cash flow (dilution-adjusted): 317647058.8235294
Buyback yield (%): 0
Retained earnings: 3737647058.8235297
Inventory turnover: 1.09579933514657
Receivables turnover: 1.2503157362970447
Capitalized R&D asset: 332422122.7621484
ROCI (R&D-adjusted, %): 4.215789532475521
Rosenberg metric: 0.6115107913669064
FCF margin (%): 5.454545454545455
Revenue growth (%): 1.9357495881383735
Rule of 40 score: 7.390295042683828
Financial ratios for CON.DE — annual report dated 2025-12-31
Total revenue: 23148235294.11765
Gross profit: 6011764705.882353
Operating income: 1802352941.1764705
Net income: -158823529.4117647
Capital expenditures: 22352941.17647059
Operating cash flow: 2580000000
Depreciation & amortization: 1865882352.9411764
Net tangible assets: 3485882352.9411764
Owner earnings: 1684705882.3529413
Capex to operating income (%): 1.2402088772845954
Buffett classification: The Great
Stock price: 76.58823529411764
Shares outstanding: 200005983
Book value: 4891764705.882355
P/B ratio: 3.1314068045454526
Market cap (USD): 15318105286.235292
Debt to equity: 1.64069264069264
Current ratio: 1.2813683071930773
Quick ratio: 0.8666846944294213
Interest coverage ratio: 4.339943342776204
COGS to revenue (%): 74.02419190892458
R&D to revenue (%): 2.851189266110998
SG&A to revenue (%): 15.241919089245782
Free cash flow (dilution-adjusted): 1315294117.647059
Buyback yield (%): 0
Retained earnings: 3757647058.8235297
Inventory turnover: 4.7489403325725466
Receivables turnover: 6.091640866873066
Capitalized R&D asset: 2542762500
ROCI (R&D-adjusted, %): 3.588739106991691
Rosenberg metric: 0.8798002219755818
FCF margin (%): 5.682049196991258
Revenue growth (%): 10.68539065773244
Rule of 40 score: 16.3674398547237
Financial ratios for CON.DE — quarterly report dated 2025-12-31
Total revenue: 5841176470.588236
Gross profit: 1485882352.9411764
Operating income: 344705882.3529412
Net income: 24705882.352941178
Capital expenditures: 14117647.05882353
Operating cash flow: 1604705882.3529413
Depreciation & amortization: 372941176.47058827
Net tangible assets: 3485882352.9411764
Owner earnings: 383529411.7647059
Return on net tangible assets (%): 11.00236247046912
Capex to operating income (%): 4.09556313993174
Buffett classification: The Great
Stock price: 76.58823529411764
P/E ratio: 155.00463682499998
Shares outstanding: 200005983
Book value: 4891764705.882355
P/B ratio: 3.1314068045454526
Market cap (USD): 15318105286.235292
Debt to equity: 1.64069264069264
Current ratio: 1.2813683071930773
Quick ratio: 0.8666846944294213
Effective tax rate (%): 87.68115942028986
Interest coverage ratio: 3.0520833333333335
COGS to revenue (%): 74.54179254783485
R&D to revenue (%): 2.618328298086606
SG&A to revenue (%): 16.555891238670696
Free cash flow (dilution-adjusted): 1221176470.5882354
Buyback yield (%): 0
Retained earnings: 3757647058.8235297
Inventory turnover: 1.2067166612324747
Receivables turnover: 1.537151702786378
Capitalized R&D asset: 320411764.7058824
ROCI (R&D-adjusted, %): 2.6745779181722886
Rosenberg metric: -0.4236111111111118
FCF margin (%): 20.90634441087613
Revenue growth (%): 0.30303030303031653
Rule of 40 score: 21.209374713906445
Financial ratios for CVV — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.13
Shares outstanding: 6940509
Market cap (USD): 28664302.169999998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVV — annual report dated 2022-12-31
Total revenue: 25813000
Gross profit: 6627000
Operating income: -1823000
Net income: -224000
Capital expenditures: 665000
Operating cash flow: 194000
Depreciation & amortization: 867000
Net tangible assets: 29280000
Owner earnings: -22000
Return on net tangible assets (%): -0.07513661202185792
Buffett classification: The Gruesome
Stock price: 5.51
Shares outstanding: 6940509
Book value: 29399000
P/B ratio: 1.3007995030443211
Market cap (USD): 38242204.589999996
Debt to equity: 0.014490288785332834
Current ratio: 2.897844194022538
Quick ratio: 2.586967172954434
Interest coverage ratio: -227.875
COGS to revenue (%): 74.32688955177623
R&D to revenue (%): 7.383876341378376
SG&A to revenue (%): 25.35156703986364
Free cash flow (dilution-adjusted): -959000
Buyback yield (%): 0
Retained earnings: 1620000
Inventory turnover: 7.559495665878645
Receivables turnover: 4.332494125545485
Capitalized R&D asset: 1906000
ROCI (R&D-adjusted, %): -1.7449084897116742
FCF margin (%): -3.715182272498353
Rule of 40 score: -3.715182272498353
Financial ratios for CVV — annual report dated 2023-12-31
Total revenue: 24109000
Gross profit: 5071000
Operating income: -4608000
Net income: -4180000
Capital expenditures: 179000
Operating cash flow: -206000
Depreciation & amortization: 792000
Net tangible assets: 26203000
Owner earnings: -3567000
Return on net tangible assets (%): -13.612945082624128
Buffett classification: The Gruesome
Stock price: 4.43
Shares outstanding: 6940509
Book value: 26203000
P/B ratio: 1.173394453688509
Market cap (USD): 30746454.869999997
Debt to equity: 0.013319085600885395
Current ratio: 2.6702127659574466
Quick ratio: 2.1495206920738834
Interest coverage ratio: -200.34782608695653
COGS to revenue (%): 78.96636110995894
R&D to revenue (%): 10.767763076029699
SG&A to revenue (%): 29.379070056825253
Free cash flow (dilution-adjusted): -1532000
Buyback yield (%): 0
Retained earnings: -2560000
Inventory turnover: 4.2743601257296815
Receivables turnover: 6.8686609686609685
Capitalized R&D asset: 3873020
ROCI (R&D-adjusted, %): -11.576141416551488
Rosenberg metric: -0.8163693599160545
FCF margin (%): -6.354473433157742
Revenue growth (%): -6.601324913803122
Rule of 40 score: -12.955798346960865
Financial ratios for CVV — quarterly report dated 2024-09-30
Capital expenditures: 37000
Buffett classification: The Gruesome
Stock price: 3.31
Shares outstanding: 6940509
Market cap (USD): 22973084.79
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVV — annual report dated 2024-12-31
Total revenue: 26876000
Gross profit: 6051000
Operating income: -3133000
Net income: -1898000
Capital expenditures: 144000
Operating cash flow: -1489000
Depreciation & amortization: 700000
Net tangible assets: 25368000
Owner earnings: -1342000
Return on net tangible assets (%): -5.290129296751813
Buffett classification: The Gruesome
Stock price: 4.4
Shares outstanding: 6940509
Book value: 25368000
P/B ratio: 1.2038095080416273
Market cap (USD): 30538239.6
Debt to equity: 0.010564490696941028
Current ratio: 3.2566400521427408
Quick ratio: 2.912009124979632
Interest coverage ratio: -164.89473684210526
COGS to revenue (%): 77.48548891204048
R&D to revenue (%): 9.7745200178598
SG&A to revenue (%): 24.39723173091234
Free cash flow (dilution-adjusted): -2658000
Buyback yield (%): 0
Retained earnings: -4458000
Inventory turnover: 9.846335697399526
Receivables turnover: 6.143085714285714
Capitalized R&D asset: 4995300
ROCI (R&D-adjusted, %): -9.436566997224796
Rosenberg metric: 0.37750385208012327
FCF margin (%): -9.889864563179044
Revenue growth (%): 11.47704176863412
Rule of 40 score: 1.5871772054550757
Financial ratios for CVV — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.4
Shares outstanding: 6940509
Market cap (USD): 30538239.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVV — quarterly report dated 2025-03-31
Total revenue: 6332000
Gross profit: 1734000
Operating income: -320000
Net income: 360000
Capital expenditures: 45000
Operating cash flow: -2262000
Depreciation & amortization: 185000
Net tangible assets: 25992000
Owner earnings: 500000
Return on net tangible assets (%): 1.9236688211757464
Buffett classification: The Gruesome
Stock price: 3.07
P/E ratio: 14.796779604166666
Shares outstanding: 6940509
Book value: 25992000
P/B ratio: 0.819766183056325
Market cap (USD): 21307362.63
Debt to equity: 0.009502923976608187
Current ratio: 3.9498884155001015
Quick ratio: 3.5366200040576183
Interest coverage ratio: -106.66666666666667
COGS to revenue (%): 72.6152874289324
R&D to revenue (%): 11.591914087176248
SG&A to revenue (%): 20.846493998736577
Free cash flow (dilution-adjusted): -2571000
Buyback yield (%): 0
Retained earnings: -4098000
Inventory turnover: 2.2572410407461954
Receivables turnover: 0.9614333434558153
Capitalized R&D asset: 734000
ROCI (R&D-adjusted, %): 0.6298431591345857
FCF margin (%): -40.60328490208465
Rule of 40 score: -40.60328490208465
Financial ratios for CVV — quarterly report dated 2025-06-30
Total revenue: 5111000
Gross profit: 1073000
Operating income: -1140000
Net income: -1061000
Capital expenditures: 4000
Operating cash flow: -3170000
Depreciation & amortization: 169000
Net tangible assets: 25181000
Owner earnings: -896000
Return on net tangible assets (%): -3.5582383543147613
Buffett classification: The Gruesome
Stock price: 2.98
Shares outstanding: 6940509
Book value: 25181000
P/B ratio: 0.8213620118343196
Market cap (USD): 20682716.82
Debt to equity: 0.00893530836741988
Current ratio: 3.997191011235955
Quick ratio: 3.4941659464131374
Interest coverage ratio: -380
COGS to revenue (%): 79.00606534924673
R&D to revenue (%): 13.422030913715515
SG&A to revenue (%): 29.876736450792407
Free cash flow (dilution-adjusted): -3424000
Buyback yield (%): 0
Retained earnings: -5159000
Inventory turnover: 1.7345360824742269
Receivables turnover: 0.5833808925921699
Capitalized R&D asset: 1177780
ROCI (R&D-adjusted, %): -3.5000605150649795
Rosenberg metric: -0.9005449591280654
FCF margin (%): -66.9927607121894
Revenue growth (%): -19.283006948831332
Rule of 40 score: -86.27576766102072
Financial ratios for CVV — quarterly report dated 2025-09-30
Total revenue: 7408000
Gross profit: 2421000
Operating income: 308000
Net income: 384000
Capital expenditures: 0
Operating cash flow: 1357000
Depreciation & amortization: 163000
Net tangible assets: 25775000
Owner earnings: 547000
Return on net tangible assets (%): 2.122211445198836
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.36
P/E ratio: 15.182363437500001
Shares outstanding: 6940509
Book value: 25775000
P/B ratio: 0.9047569443258971
Market cap (USD): 23320110.24
Debt to equity: 0.007875848690591658
Current ratio: 4.757396449704142
Quick ratio: 4.2397736043220995
Effective tax rate (%): 0
Interest coverage ratio: 102.66666666666667
COGS to revenue (%): 67.31911447084234
R&D to revenue (%): 8.018358531317494
SG&A to revenue (%): 20.5048596112311
Free cash flow (dilution-adjusted): 1147000
Buyback yield (%): 0
Retained earnings: -4775000
Inventory turnover: 2.478628230616302
Receivables turnover: 0.971413585103593
Capitalized R&D asset: 1295840
ROCI (R&D-adjusted, %): 0.8485433502649612
Rosenberg metric: 1.9650145772594751
FCF margin (%): 15.483261339092872
Revenue growth (%): 44.94228135394248
Rule of 40 score: 60.42554269303535
Financial ratios for CVV — annual report dated 2025-12-31
Total revenue: 25786000
Gross profit: 7288000
Operating income: -1747000
Net income: -1585000
Capital expenditures: 48000
Operating cash flow: -3678000
Depreciation & amortization: 700000
Net tangible assets: 24725000
Owner earnings: -933000
Return on net tangible assets (%): -3.773508594539939
Buffett classification: The Gruesome
Stock price: 3.09
Shares outstanding: 6940509
Book value: 24725000
P/B ratio: 0.8673881824064712
Market cap (USD): 21446172.81
Debt to equity: 0.007320525783619818
Current ratio: 6.064655172413793
Quick ratio: 5.501436781609195
Interest coverage ratio: -134.3846153846154
COGS to revenue (%): 71.73660125649577
R&D to revenue (%): 10.80431241759094
SG&A to revenue (%): 24.234080508803228
Free cash flow (dilution-adjusted): -4668000
Buyback yield (%): 0
Retained earnings: -6043000
Inventory turnover: 11.79719387755102
Receivables turnover: 4.519894829097283
Capitalized R&D asset: 5402770
ROCI (R&D-adjusted, %): -5.412503702287513
Rosenberg metric: 0.47087933003425964
FCF margin (%): -18.10284650585589
Revenue growth (%): -4.055663045095996
Rule of 40 score: -22.158509550951887
Financial ratios for CVV — quarterly report dated 2025-12-31
Total revenue: 4950000
Gross profit: 1098000
Operating income: -1184000
Net income: -1268000
Capital expenditures: 1000
Operating cash flow: 397000
Depreciation & amortization: 166000
Net tangible assets: 24725000
Owner earnings: -1103000
Return on net tangible assets (%): -4.461071789686552
Buffett classification: The Gruesome
Stock price: 3.09
Shares outstanding: 6940509
Book value: 24725000
P/B ratio: 0.8673881824064712
Market cap (USD): 21446172.81
Debt to equity: 0.007320525783619818
Current ratio: 6.064655172413793
Quick ratio: 5.501436781609195
Interest coverage ratio: -394.6666666666667
COGS to revenue (%): 77.81818181818181
R&D to revenue (%): 14.646464646464647
SG&A to revenue (%): 31.454545454545457
Free cash flow (dilution-adjusted): 180000
Buyback yield (%): 0
Retained earnings: -6043000
Inventory turnover: 2.4566326530612246
Receivables turnover: 0.8676599474145487
Capitalized R&D asset: 1349360
ROCI (R&D-adjusted, %): -4.323532133994213
Rosenberg metric: -2.227272727272727
FCF margin (%): 3.6363636363636362
Revenue growth (%): -33.18034557235421
Rule of 40 score: -29.543981935990576
Financial ratios for DCTH — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.75
Shares outstanding: 34521647
Market cap (USD): 267542764.25
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DCTH — annual report dated 2022-12-31
Total revenue: 2719000
Gross profit: 2033000
Operating income: -33853000
Net income: -36508000
Capital expenditures: 209000
Operating cash flow: -24950000
Depreciation & amortization: 132000
Net tangible assets: -5859000
Owner earnings: -36585000
Buffett classification: The Gruesome
Stock price: 3.6
Shares outstanding: 34521647
Book value: -5859000
Market cap (USD): 124277929.2
Debt to equity: -2.709336064174774
Current ratio: 1.0963691890057685
Quick ratio: 0.9607736681370885
Interest coverage ratio: -12.608193668528864
COGS to revenue (%): 25.22986392055903
R&D to revenue (%): 683.4497977197499
SG&A to revenue (%): 636.3736667892607
Free cash flow (dilution-adjusted): -33100000
Buyback yield (%): 0
Retained earnings: -457484000
Inventory turnover: 0.3433433433433433
Receivables turnover: 7.4289617486338795
Capitalized R&D asset: 18583000
ROCI (R&D-adjusted, %): -98.86841701212958
FCF margin (%): -1217.359323280618
Rule of 40 score: -1217.359323280618
Financial ratios for DCTH — annual report dated 2023-12-31
Total revenue: 2065000
Gross profit: 1430000
Operating income: -38182000
Net income: -47678000
Capital expenditures: 58000
Operating cash flow: -31251000
Depreciation & amortization: 399000
Net tangible assets: 15777000
Owner earnings: -47337000
Return on net tangible assets (%): -300.0380300437345
Buffett classification: The Gruesome
Stock price: 4.16
Shares outstanding: 34521647
Book value: 15777000
P/B ratio: 9.102494233377701
Market cap (USD): 143610051.52
Debt to equity: 0.6456867592064398
Current ratio: 2.2591196498054473
Quick ratio: 2.057149805447471
Interest coverage ratio: -26.533703961084086
COGS to revenue (%): 30.750605326876514
R&D to revenue (%): 847.5544794188861
SG&A to revenue (%): 1070.7021791767554
Free cash flow (dilution-adjusted): -39460000
Buyback yield (%): 0
Retained earnings: -505162000
Inventory turnover: 0.19114990969295606
Receivables turnover: 4.27536231884058
Capitalized R&D asset: 29952610
ROCI (R&D-adjusted, %): -62.75869774790773
Rosenberg metric: -0.032449012538341496
FCF margin (%): -1910.8958837772398
Revenue growth (%): -24.0529606472968
Rule of 40 score: -1934.9488444245367
Financial ratios for DCTH — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.03
Shares outstanding: 34521647
Market cap (USD): 311730472.40999997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DCTH — annual report dated 2024-12-31
Total revenue: 37205000
Gross profit: 31017000
Operating income: -12410000
Net income: -26386000
Capital expenditures: 559000
Operating cash flow: -18681000
Depreciation & amortization: 229000
Net tangible assets: 68746000
Owner earnings: -26716000
Return on net tangible assets (%): -38.861897419486226
Buffett classification: The Gruesome
Stock price: 12.04
Shares outstanding: 34521647
Book value: 68746000
P/B ratio: 6.04603365839467
Market cap (USD): 415640629.88
Debt to equity: 0.01509906030896343
Current ratio: 12.005208333333334
Quick ratio: 10.876790364583334
COGS to revenue (%): 16.63217309501411
R&D to revenue (%): 37.29068673565381
SG&A to revenue (%): 79.43287192581641
Free cash flow (dilution-adjusted): -29007000
Buyback yield (%): 0
Retained earnings: -531548000
Inventory turnover: 0.8925429107168614
Receivables turnover: 3.3639240506329116
Capitalized R&D asset: 31732730
ROCI (R&D-adjusted, %): -14.865274458534165
Rosenberg metric: 1.6904925151411268
FCF margin (%): -77.96532724096224
Revenue growth (%): 1701.6949152542375
Rule of 40 score: 1623.7295880132751
Financial ratios for DCTH — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.04
Shares outstanding: 34521647
Market cap (USD): 415640629.88
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DCTH — quarterly report dated 2025-03-31
Total revenue: 19784000
Gross profit: 16939000
Operating income: 642000
Net income: 1069000
Capital expenditures: 140000
Operating cash flow: 2203000
Depreciation & amortization: 67000
Net tangible assets: 80230000
Owner earnings: 996000
Return on net tangible assets (%): 1.2414308862021688
Capex to operating income (%): 21.806853582554517
Buffett classification: The Great
Stock price: 12.73
P/E ratio: 102.77375264499533
Shares outstanding: 34521647
Book value: 80230000
P/B ratio: 5.477509239810544
Market cap (USD): 439460566.31
Debt to equity: 0.01266359217250405
Current ratio: 15.95403820692264
Quick ratio: 14.605069037261206
Effective tax rate (%): 15.427215189873417
COGS to revenue (%): 14.380307319045693
R&D to revenue (%): 25.30832996360696
SG&A to revenue (%): 57.06631621512334
Free cash flow (dilution-adjusted): -4800000
Buyback yield (%): 0
Retained earnings: -530479000
Inventory turnover: 0.3989063376332025
Receivables turnover: 1.3757040539600862
Capitalized R&D asset: 5007000
ROCI (R&D-adjusted, %): 4.572662829306403
FCF margin (%): -24.26202992317024
Rule of 40 score: -24.26202992317024
Financial ratios for DCTH — quarterly report dated 2025-06-30
Total revenue: 24156000
Gross profit: 20838000
Operating income: 2590000
Net income: 2697000
Capital expenditures: 398000
Operating cash flow: 7293000
Depreciation & amortization: 27000
Net tangible assets: 104986000
Owner earnings: 2326000
Return on net tangible assets (%): 2.2155334997047227
Capex to operating income (%): 15.366795366795365
Buffett classification: The Great
Stock price: 13.6
P/E ratio: 124.66659564524694
Shares outstanding: 34521647
Book value: 104986000
P/B ratio: 4.471971493341969
Market cap (USD): 469494399.2
Debt to equity: 0.009458403977673214
Current ratio: 10.875131768088165
Quick ratio: 9.866698610445615
Effective tax rate (%): 15.850234009360376
COGS to revenue (%): 13.73571783407849
R&D to revenue (%): 28.48981619473423
SG&A to revenue (%): 47.05249213445934
Free cash flow (dilution-adjusted): -314000
Buyback yield (%): 0
Retained earnings: -527782000
Inventory turnover: 0.3153093224365675
Receivables turnover: 1.4401717045251297
Capitalized R&D asset: 10236690
ROCI (R&D-adjusted, %): 4.7215538806090525
Rosenberg metric: 0.7787098062712203
FCF margin (%): -1.2998840867693326
Revenue growth (%): 22.098665588354223
Rule of 40 score: 20.79878150158489
Financial ratios for DCTH — quarterly report dated 2025-09-30
Total revenue: 20563000
Gross profit: 17939000
Operating income: -388000
Net income: 830000
Capital expenditures: 459000
Operating cash flow: 4772000
Depreciation & amortization: 146000
Net tangible assets: 114847000
Owner earnings: 517000
Return on net tangible assets (%): 0.45016413140961453
Buffett classification: The Gruesome
Stock price: 10.75
P/E ratio: 80.74580183855527
Shares outstanding: 34521647
Book value: 114847000
P/B ratio: 3.231322587877785
Market cap (USD): 371107705.25
Debt to equity: 0.00840248330387385
Current ratio: 15.056172762451629
Quick ratio: 13.714892023467732
Effective tax rate (%): -121.33333333333334
COGS to revenue (%): 12.760783932305596
R&D to revenue (%): 38.836745611048975
SG&A to revenue (%): 50.289354666147936
Free cash flow (dilution-adjusted): -1335000
Buyback yield (%): 0
Retained earnings: -526952000
Inventory turnover: 0.24420660772452304
Receivables turnover: 1.3211899254690311
Capitalized R&D asset: 14249250
ROCI (R&D-adjusted, %): 0.7454039488023166
Rosenberg metric: -0.42124382446963093
FCF margin (%): -6.492243349705783
Revenue growth (%): -14.874151349561185
Rule of 40 score: -21.36639469926697
Financial ratios for DCTH — annual report dated 2025-12-31
Total revenue: 85231000
Gross profit: 73434000
Operating income: 660000
Net income: 2700000
Capital expenditures: 1547000
Operating cash flow: 22516000
Depreciation & amortization: 349000
Net tangible assets: 111219000
Owner earnings: 1502000
Return on net tangible assets (%): 1.3504886754960932
Capex to operating income (%): 234.39393939393938
Buffett classification: The Gruesome
Stock price: 10.1
P/E ratio: 129.13653137037036
Shares outstanding: 34521647
Book value: 111219000
P/B ratio: 3.1349736528830503
Market cap (USD): 348668634.7
Debt to equity: 0.008415828230787905
Current ratio: 10.915981735159818
Quick ratio: 9.97972602739726
Effective tax rate (%): 23.076923076923077
COGS to revenue (%): 13.841208011169645
R&D to revenue (%): 34.31380600955052
SG&A to revenue (%): 51.07061984489212
Free cash flow (dilution-adjusted): -3263000
Buyback yield (%): 1.7208315870346338
Retained earnings: -528848000
Inventory turnover: 1.1507023019898557
Receivables turnover: 6.587139655305665
Capitalized R&D asset: 44317240
ROCI (R&D-adjusted, %): 6.177524596085095
Rosenberg metric: 3.0573014271298833
FCF margin (%): -3.8284192371320294
Revenue growth (%): 129.08480043004974
Rule of 40 score: 125.25638119291771
Financial ratios for DCTH — quarterly report dated 2025-12-31
Total revenue: 20728000
Gross profit: 17718000
Operating income: -2184000
Net income: -1896000
Capital expenditures: 550000
Operating cash flow: 8248000
Depreciation & amortization: 109000
Net tangible assets: 111219000
Owner earnings: -2337000
Return on net tangible assets (%): -2.101259676853775
Buffett classification: The Gruesome
Stock price: 10.1
P/E ratio: 129.13653137037036
Shares outstanding: 34521647
Book value: 111219000
P/B ratio: 3.1349736528830503
Market cap (USD): 348668634.7
Debt to equity: 0.008415828230787905
Current ratio: 10.915981735159818
Quick ratio: 9.97972602739726
COGS to revenue (%): 14.521420301042069
R&D to revenue (%): 45.209378618294096
SG&A to revenue (%): 50.805673485140865
Free cash flow (dilution-adjusted): 3186000
Buyback yield (%): 0
Retained earnings: -528848000
Inventory turnover: 0.29360124853687086
Receivables turnover: 1.6019785145683592
Capitalized R&D asset: 16992680
ROCI (R&D-adjusted, %): -0.6883893344997396
Rosenberg metric: -0.02767342849987478
FCF margin (%): 15.37051331532227
Revenue growth (%): 0.8024120994018382
Rule of 40 score: 16.17292541472411
Financial ratios for DG.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 87.98863636363637
Shares outstanding: 553842409
Market cap (USD): 48731838328.26137
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DG.PA — annual report dated 2022-12-31
Total revenue: 66504255319.14894
Gross profit: 37480851063.82979
Operating income: 6812765957.446809
Net income: 4698936170.212767
Capital expenditures: 3548936170.212766
Operating cash flow: 9986170212.765959
Depreciation & amortization: 3844680851.06383
Net tangible assets: -30520212765.957447
Owner earnings: 4994680851.063829
Return on net tangible assets (%): -16.36515737739203
Capex to operating income (%): 52.09244222361025
Buffett classification: The Good
Stock price: 85.62765957446808
P/E ratio: 10.092545958888383
Shares outstanding: 553842409
Book value: 31286170212.76596
P/B ratio: 1.5158208541742322
Market cap (USD): 47424229255.75532
Debt to equity: 1.05488115882893
Current ratio: 0.8639179529679892
Quick ratio: 0.8269346317207086
Effective tax rate (%): 28.22554436139097
Interest coverage ratio: 7.906172839506173
COGS to revenue (%): 43.641424320952105
SG&A to revenue (%): 10.692004990882042
Free cash flow (dilution-adjusted): 6089361702.12766
Buyback yield (%): 2.4675419808017898
Retained earnings: 4530851063.829787
Inventory turnover: 15.284033613445377
Receivables turnover: 3.455339376520009
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.04927345196623
FCF margin (%): 9.156348977828966
Rule of 40 score: 9.156348977828966
Financial ratios for DG.PA — annual report dated 2023-12-31
Total revenue: 77650000000
Gross profit: 43972222222.22222
Operating income: 8928888888.88889
Net income: 5668888888.888888
Capital expenditures: 3537777777.7777777
Operating cash flow: 11711111111.11111
Depreciation & amortization: 4222222222.2222223
Net tangible assets: -29446666666.666664
Owner earnings: 6353333333.333333
Return on net tangible assets (%): -21.575730133574826
Capex to operating income (%): 39.62170233947237
Buffett classification: The Good
Stock price: 113.14444444444445
P/E ratio: 11.054051844074875
Shares outstanding: 553842409
Book value: 35601111111.111115
P/B ratio: 1.7601751664576635
Market cap (USD): 62664191676.07778
Debt to equity: 0.9807122124777627
Current ratio: 0.9092028683233022
Quick ratio: 0.8718987744075642
Effective tax rate (%): 27.31158284655934
Interest coverage ratio: 6.839148936170213
COGS to revenue (%): 43.37125277241182
SG&A to revenue (%): 10.853545109823282
Free cash flow (dilution-adjusted): 7863333333.333333
Buyback yield (%): 0.70392851054601
Retained earnings: 5224444444.444445
Inventory turnover: 16.139510117145903
Receivables turnover: 7.91718590687663
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.780400205233452
FCF margin (%): 10.126636617299848
Revenue growth (%): 16.75944588412195
Rule of 40 score: 26.886082501421797
Financial ratios for DG.PA — annual report dated 2024-12-31
Total revenue: 75800000000
Gross profit: 44107291666.66667
Operating income: 8935416666.666668
Net income: 5493750000
Capital expenditures: 4043750000
Operating cash flow: 12202083333.333334
Depreciation & amortization: 4164583333.3333335
Net tangible assets: -32321875000
Owner earnings: 5614583333.333334
Return on net tangible assets (%): -17.37084662734861
Capex to operating income (%): 45.255304266728835
Buffett classification: The Good
Stock price: 96.90625
P/E ratio: 9.769427248629125
Shares outstanding: 553842409
Book value: 35450000000
P/B ratio: 1.5139856402582863
Market cap (USD): 53670790947.15625
Debt to equity: 1.065497179125529
Current ratio: 0.8527792415459815
Quick ratio: 0.8205803790453
Effective tax rate (%): 28.497830802603037
Interest coverage ratio: 6.0836879432624125
COGS to revenue (%): 41.81096086191733
Free cash flow (dilution-adjusted): 7741666666.666667
Buyback yield (%): 3.710894942143936
Retained earnings: 5065625000
Inventory turnover: 17.169864559819413
Receivables turnover: 8.313492516851365
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.520588788310189
FCF margin (%): 10.213280562884785
Revenue growth (%): -2.3824855119124275
Rule of 40 score: 7.830795050972357
Financial ratios for DG.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -32321875000
Buffett classification: The Gruesome
Stock price: 96.90625
Shares outstanding: 553842409
Book value: 35450000000
P/B ratio: 1.5139856402582863
Market cap (USD): 53670790947.15625
Debt to equity: 1.065497179125529
Current ratio: 0.8527792415459815
Quick ratio: 0.8205803790453
Buyback yield (%): 0
Retained earnings: 5065625000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DG.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -36802352941.17647
Buffett classification: The Gruesome
Stock price: 141.65882352941176
Shares outstanding: 553842409
Book value: 38141176470.58823
P/B ratio: 2.0570069237412096
Market cap (USD): 78456664079.6353
Debt to equity: 1.2132634176434303
Current ratio: 0.8321380045749273
Quick ratio: 0.8010422578814302
Buyback yield (%): 0
Retained earnings: 2230588235.294118
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DLB — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 81.6
Shares outstanding: 60346214
Market cap (USD): 4924251062.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DLB — annual report dated 2022-09-30
Total revenue: 1253793000
Gross profit: 1112433000
Operating income: 217228000
Net income: 184087000
Capital expenditures: 47928000
Operating cash flow: 318576000
Depreciation & amortization: 103609000
Net tangible assets: 1768771000
Owner earnings: 239768000
Return on net tangible assets (%): 13.55562704273193
Capex to operating income (%): 22.063454066694902
Buffett classification: The Great
Stock price: 61.19
P/E ratio: 20.05891146392738
Shares outstanding: 60346214
Book value: 2251020000
P/B ratio: 1.6404051650629492
Market cap (USD): 3692584834.66
Debt to equity: 0.02263062967010511
Current ratio: 4.723635944335142
Quick ratio: 4.638780187231099
Effective tax rate (%): 14.576897885999099
Interest coverage ratio: 551.3401015228426
COGS to revenue (%): 11.274588388992441
R&D to revenue (%): 20.83071128966265
SG&A to revenue (%): 50.56903332527778
Free cash flow (dilution-adjusted): 144195000
Buyback yield (%): 15.352497650936122
Retained earnings: 2297730000
Inventory turnover: 6.002802666779906
Receivables turnover: 2.9874549067636282
Capitalized R&D asset: 261174000
ROCI (R&D-adjusted, %): 14.639511238199553
FCF margin (%): 11.500702269034841
Rule of 40 score: 11.500702269034841
Financial ratios for DLB — annual report dated 2023-09-30
Total revenue: 1299744000
Gross profit: 1147178000
Operating income: 262814000
Net income: 201644000
Capital expenditures: 30339000
Operating cash flow: 367081000
Depreciation & amortization: 95514000
Net tangible assets: 1779264000
Owner earnings: 266819000
Return on net tangible assets (%): 14.996032067191829
Capex to operating income (%): 11.543905575806464
Buffett classification: The Great
Stock price: 75.47
P/E ratio: 22.585987039435835
Shares outstanding: 60346214
Book value: 2372184000
P/B ratio: 1.9198884954033921
Market cap (USD): 4554328770.58
Debt to equity: 0.021350788977583527
Current ratio: 3.5237147878150563
Quick ratio: 3.4393452795422355
Effective tax rate (%): 19.35949578689318
COGS to revenue (%): 11.73815766797154
R&D to revenue (%): 20.89049843661521
SG&A to revenue (%): 47.15090048501859
Free cash flow (dilution-adjusted): 218256000
Buyback yield (%): 3.9615058351842105
Retained earnings: 2391990000
Inventory turnover: 4.282794823569042
Receivables turnover: 2.924881012658228
Capitalized R&D asset: 446509580
ROCI (R&D-adjusted, %): 11.876346372862907
Rosenberg metric: 0.13303391608659362
FCF margin (%): 16.792229854494423
Revenue growth (%): 3.664959048263948
Rule of 40 score: 20.45718890275837
Financial ratios for DLB — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 73.98
Shares outstanding: 60346214
Market cap (USD): 4464412911.72
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DLB — annual report dated 2024-09-30
Total revenue: 1273721000
Gross profit: 1133225000
Operating income: 264710000
Net income: 264316000
Capital expenditures: 30007000
Operating cash flow: 327252000
Depreciation & amortization: 87327000
Net tangible assets: 1509440000
Owner earnings: 321636000
Return on net tangible assets (%): 21.308299766800936
Capex to operating income (%): 11.335801443088663
Buffett classification: The Great
Stock price: 73.98
P/E ratio: 16.89043762662873
Shares outstanding: 60346214
Book value: 2486893000
P/B ratio: 1.7951769182349222
Market cap (USD): 4464412911.72
Debt to equity: 0.018895867252833154
Current ratio: 2.8585784853387453
Quick ratio: 2.7778578198144728
Effective tax rate (%): 15.413195766755525
COGS to revenue (%): 11.030359081776936
R&D to revenue (%): 20.700216138385095
SG&A to revenue (%): 47.48700853640632
Free cash flow (dilution-adjusted): 177420000
Buyback yield (%): 4.459175348171416
Retained earnings: 2496255000
Inventory turnover: 4.165559772296016
Receivables turnover: 2.4831628465541007
Capitalized R&D asset: 531770830
ROCI (R&D-adjusted, %): 8.155423494450185
Rosenberg metric: -0.05138791188960051
FCF margin (%): 13.929267084392894
Revenue growth (%): -2.002163502966738
Rule of 40 score: 11.927103581426156
Financial ratios for DLB — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 75.8
Shares outstanding: 60346214
Market cap (USD): 4574243021.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DLB — quarterly report dated 2025-03-31
Total revenue: 369561000
Gross profit: 333724000
Operating income: 111973000
Net income: 92226000
Capital expenditures: 6897000
Operating cash flow: 174897000
Depreciation & amortization: 46789000
Net tangible assets: 1636586000
Owner earnings: 132118000
Return on net tangible assets (%): 8.072780776567805
Capex to operating income (%): 6.159520598715762
Buffett classification: The Great
Stock price: 78.25
P/E ratio: 12.800325411218093
Shares outstanding: 60346214
Book value: 2583019000
P/B ratio: 1.828128730566829
Market cap (USD): 4722091245.5
Debt to equity: 0.015652614247127102
Current ratio: 3.036777162092746
Quick ratio: 2.9611593822748286
Effective tax rate (%): 23.304781704781703
COGS to revenue (%): 9.697181250186032
R&D to revenue (%): 16.69737878185198
SG&A to revenue (%): 43.30651773320236
Free cash flow (dilution-adjusted): 137336000
Buyback yield (%): 0.7731532090743035
Retained earnings: 2601552000
Inventory turnover: 1.035931086315546
Receivables turnover: 0.6787586369029471
Capitalized R&D asset: 61707000
ROCI (R&D-adjusted, %): 5.40406133151305
FCF margin (%): 37.161929965553725
Rule of 40 score: 37.161929965553725
Financial ratios for DLB — quarterly report dated 2025-06-30
Total revenue: 315546000
Gross profit: 271544000
Operating income: 47092000
Net income: 46542000
Capital expenditures: 6428000
Operating cash flow: 67691000
Depreciation & amortization: 24398000
Net tangible assets: 1667760000
Owner earnings: 64512000
Return on net tangible assets (%): 3.8681824722981726
Capex to operating income (%): 13.649876836830035
Buffett classification: The Great
Stock price: 72.67
P/E ratio: 31.602093936498328
Shares outstanding: 60346214
Book value: 2614251000
P/B ratio: 1.6774821435967704
Market cap (USD): 4385359371.38
Debt to equity: 0.014960307942886893
Current ratio: 3.4417968800236634
Quick ratio: 3.3584217498103066
Effective tax rate (%): 16.16470927300238
COGS to revenue (%): 13.944718044278806
R&D to revenue (%): 20.910421935312126
SG&A to revenue (%): 50.22088697052094
Free cash flow (dilution-adjusted): 30535000
Buyback yield (%): 0.9393756933319838
Retained earnings: 2618163000
Inventory turnover: 1.3574579669905908
Receivables turnover: 0.628583950039343
Capitalized R&D asset: 107325690
ROCI (R&D-adjusted, %): 2.419282600826341
Rosenberg metric: -1.0076652567779993
FCF margin (%): 9.676877539249427
Revenue growth (%): -14.615990323654282
Rule of 40 score: -4.9391127844048555
Financial ratios for DLB — annual report dated 2025-09-30
Total revenue: 1349130000
Gross profit: 1188998000
Operating income: 279966000
Net income: 256492000
Capital expenditures: 36348000
Operating cash flow: 472198000
Depreciation & amortization: 98597000
Net tangible assets: 1695600000
Owner earnings: 318741000
Return on net tangible assets (%): 18.798124557678697
Capex to operating income (%): 12.983005079188187
Buffett classification: The Great
Stock price: 71.15
P/E ratio: 16.739832533178422
Shares outstanding: 60346214
Book value: 2631946000
P/B ratio: 1.6313530467950332
Market cap (USD): 4293633126.1000004
Debt to equity: 0.014771579660069013
Current ratio: 3.171066036227415
Quick ratio: 3.1015715297288655
Effective tax rate (%): 15.484455574410596
COGS to revenue (%): 11.869278720360528
R&D to revenue (%): 19.40450512552534
SG&A to revenue (%): 47.97462068147621
Free cash flow (dilution-adjusted): 301743000
Buyback yield (%): 3.778338652500457
Retained earnings: 2634980000
Inventory turnover: 5.263344727846437
Receivables turnover: 2.6355342840398515
Capitalized R&D asset: 528048800
ROCI (R&D-adjusted, %): 8.32119054499229
Rosenberg metric: 0.2115313866564516
FCF margin (%): 22.365746814613864
Revenue growth (%): 5.920370316576394
Rule of 40 score: 28.28611713119026
Financial ratios for DLB — quarterly report dated 2025-09-30
Total revenue: 307024000
Gross profit: 267505000
Operating income: 35805000
Net income: 49654000
Capital expenditures: 16244000
Operating cash flow: 122831000
Depreciation & amortization: 24575000
Net tangible assets: 1695600000
Owner earnings: 57985000
Return on net tangible assets (%): 3.419733427695211
Capex to operating income (%): 45.36796536796537
Buffett classification: The Good
Stock price: 71.15
P/E ratio: 22.787323805606565
Shares outstanding: 60346214
Book value: 2631946000
P/B ratio: 1.6313530467950332
Market cap (USD): 4293633126.1000004
Debt to equity: 0.014771579660069013
Current ratio: 3.171066036227415
Quick ratio: 3.1015715297288655
Effective tax rate (%): -19.165786694825766
COGS to revenue (%): 12.87163218510605
R&D to revenue (%): 21.97385220699359
SG&A to revenue (%): 53.49256084214915
Free cash flow (dilution-adjusted): 69942000
Buyback yield (%): 0.8636974541344709
Retained earnings: 2634980000
Inventory turnover: 1.2989416250328687
Receivables turnover: 0.5997733932408673
Capitalized R&D asset: 132036250
ROCI (R&D-adjusted, %): 1.3079597850506537
Rosenberg metric: -0.061213664332696795
FCF margin (%): 22.780629527333367
Revenue growth (%): -2.7007155850494065
Rule of 40 score: 20.079913942283962
Financial ratios for DLB — quarterly report dated 2025-12-31
Total revenue: 346706000
Gross profit: 303498000
Operating income: 72626000
Net income: 53681000
Capital expenditures: 4628000
Operating cash flow: 54799000
Depreciation & amortization: 26813000
Net tangible assets: 1699355000
Owner earnings: 75866000
Return on net tangible assets (%): 4.464399728132144
Capex to operating income (%): 6.372373530140721
Buffett classification: The Great
Stock price: 63.47
P/E ratio: 15.820432636439861
Shares outstanding: 60346214
Book value: 2602871000
P/B ratio: 1.471519027481577
Market cap (USD): 3830174202.58
Debt to equity: 0.015613144101263566
Current ratio: 3.174836022881262
Quick ratio: 3.1043433361818416
Effective tax rate (%): 25.028630485181978
COGS to revenue (%): 12.462432147121769
R&D to revenue (%): 19.923797107635867
SG&A to revenue (%): 46.666339780678726
Free cash flow (dilution-adjusted): 12210000
Buyback yield (%): 2.6422035825898247
Retained earnings: 2604358000
Inventory turnover: 1.3820368474923235
Receivables turnover: 0.6068115031407684
Capitalized R&D asset: 136052610
ROCI (R&D-adjusted, %): 2.5720458753146
Rosenberg metric: 0.5335062625064848
FCF margin (%): 3.5217158053220885
Revenue growth (%): 12.924722497264057
Rule of 40 score: 16.446438302586145
Financial ratios for EG7.IR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.579545454545455
Shares outstanding: 40472514
Market cap (USD): 185345717.52272728
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EG7.IR — annual report dated 2022-12-31
Total revenue: 339698936.1702128
Net income: 61229787.234042555
Capital expenditures: 1370212.765957447
Operating cash flow: 109304255.31914894
Depreciation & amortization: 14922340.425531916
Net tangible assets: 471113829.78723407
Owner earnings: 74781914.89361703
Return on net tangible assets (%): 15.873428068836418
Buffett classification: The Gruesome
Stock price: 7.127659574468086
P/E ratio: 4.711339283480437
Shares outstanding: 40472514
Book value: 486094680.85106385
P/B ratio: 0.5934529080010242
Market cap (USD): 288474301.9148936
Debt to equity: 0.11875367945567036
Effective tax rate (%): 12.582017010935603
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 92791489.36170214
Buyback yield (%): 0
Retained earnings: 479061702.1276596
Receivables turnover: 7.806116462132694
Capitalized R&D asset: 0
FCF margin (%): 27.31580216524645
Rule of 40 score: 27.31580216524645
Financial ratios for EG7.IR — annual report dated 2023-12-31
Total revenue: 404544444.4444444
Net income: 77267777.77777778
Capital expenditures: 2431111.111111111
Operating cash flow: 72321111.1111111
Depreciation & amortization: 14221111.11111111
Net tangible assets: 482553333.3333333
Owner earnings: 89057777.77777778
Return on net tangible assets (%): 18.45553053433357
Buffett classification: The Gruesome
Stock price: 8.933333333333332
P/E ratio: 4.679239765893501
Shares outstanding: 40472514
Book value: 533287777.7777779
P/B ratio: 0.6779725196527201
Market cap (USD): 361554458.3999999
Debt to equity: 0.11156994659960535
Effective tax rate (%): 14.579290013511853
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 50348888.88888889
Buyback yield (%): 0
Retained earnings: 494018888.8888889
Capitalized R&D asset: 0
FCF margin (%): 12.44582383476613
Revenue growth (%): 19.08911137765221
Rule of 40 score: 31.53493521241834
Financial ratios for EG7.IR — annual report dated 2024-12-31
Total revenue: 430716666.6666667
Net income: 70005208.33333334
Capital expenditures: 4797916.666666667
Operating cash flow: 87635416.66666667
Depreciation & amortization: 16717708.333333334
Net tangible assets: 456862500
Owner earnings: 81925000
Return on net tangible assets (%): 17.932091165284962
Buffett classification: The Gruesome
Stock price: 10.875
P/E ratio: 6.287226339706867
Shares outstanding: 40472514
Book value: 506382291.66666675
P/B ratio: 0.8691824279663543
Market cap (USD): 440138589.75
Debt to equity: 0.1086876474666085
Effective tax rate (%): 12.794394342438201
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 67450000
Buyback yield (%): 0.9466715174948295
Retained earnings: 463815625
Capitalized R&D asset: 0
FCF margin (%): 15.659946600626862
Revenue growth (%): 6.469554231096719
Rule of 40 score: 22.129500831723583